Journal Information
Vol. 61. Issue 5.
Pages 315-316 (May 2025)
Share
Download PDF
More article options
Vol. 61. Issue 5.
Pages 315-316 (May 2025)
Clinical Letter
Real-world Management of COPD: Dupilumab's Role in Targeting T2 Inflammation as a Treatable Trait
Visits
2067
Miguel Jiménez-Gómez
Corresponding author
migueljimenezgomez@gmail.com

Corresponding author.
, Rocío Magdalena Díaz-Campos, Marta Padilla-Bernáldez, Cristina Almeida-Calderero, Ascensión Hernando-Sanz
Pulmonology Department, 12th of October University Hospital, Madrid, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Table 1. Clinical and Functional Characteristics of COPD Patients Under Treatment With Dupilumab.
Tables

Article

These are the options to access the full texts of the publication Archivos de Bronconeumología
Member
If you are a member of SEPAR:
  • Go to >>>SEPAR<<< website and sign in.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?